Skip to main content
SpringerLink
Log in

Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology

Scientific and Clinical Aspects of Anemia in Cancer

  • Book
  • © 2002

Overview

Editors:
  1. M. R. Nowrousian

    1. Innere Klinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Essen, Universitätsklinikum, Essen, Deutschland

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Comprehensive presentation of anemia in cancer and its treatment
  • Assessment of current and potential applications of erythopoietin
  • Presented by world experts in the field

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (26 chapters)

  1. Front Matter

    Pages i-ix
    Download chapter PDF

  2. Biology of erythropoietin

    • Catherine Lacombe, P. Mayeux
    Pages 1-21

  3. Classification and characterization of anemia in cancer

    • M. R. Nowrousian
    Pages 23-38

  4. Pathophysiology of cancer-related anemia

    • M. R. Nowrousian
    Pages 39-62

  5. Prevalence, pathophysiology, predictive factors, and prognostic significance of anemia in cancer chemotherapy

    • M. R. Nowrousian
    Pages 63-100

  6. Incidence and impact of anemia in radiation oncology

    • Jürgen Dunst, M. Molls
    Pages 101-115

  7. Relationship between anemia and tumor hypoxia

    • Jürgen Dunst, M. Molls
    Pages 117-125

  8. Tumor hypoxia and therapeutic resistance

    • Peter Vaupel, Michael Höckel
    Pages 127-146

  9. Impact of anemia on organ functions

    • M. R. Nowrousian
    Pages 147-172

  10. Relationship between anemia, fatigue, and quality of life in cancer patients

    • Yvonne Brandberg
    Pages 173-184

  11. Red blood cell transfusion, risks and limitations

    • Francesco Mercuriali, G. Inghilleri
    Pages 185-201

  12. Pharmacology, pharmacokinetics and safety of recombinant human erythropoietin (rhEPO)

    • Wolfgang Jelkmann
    Pages 203-221

  13. Recombinant human erythropoietin (rhEPO) in anemia associated with multiple myeloma and non-Hodgkin’s lymphoma

    • Anders Österborg
    Pages 223-234

  14. Use of recombinant human erythropoietin in the treatment of myelodysplastic syndromes

    • Mario Cazzola
    Pages 235-239

  15. rhEPO in anemia associated with solid tumors and chemotherapy

    • M. R. Nowrousian
    Pages 241-262

  16. Predictive factors for response of anemia to recombinant human erythropoietin

    • Yves Beguin
    Pages 263-286

  17. rhEPO in hematopoietic stem cell mobilization, transplantation and in-vitro expansion

    • Sven Klaesson
    Pages 287-299

  18. Clinical trials using rhEPO in radiation oncology

    • Michael Henke
    Pages 301-311

  19. rhEPO in pediatric oncology

    • Carlo Cappelli, G. Ragni, A. Clerico
    Pages 313-323

  20. rHuEPO in surgical oncology

    • Francesco Mercuriali, G. Inghilleri
    Pages 325-346
Back to top

Keywords

About this book

Anemia is a frequent complication of cancer and its treatment. A number of clinical studies shows that the impact of anemia is much greater than previously thought. Beyond clinical symptoms, anemia significantly impairs physical and metabolic functions as well as patients' activity, well-being and quality of life. Life expectancy is also affected. In this book, written by a group of outstanding international experts, the current knowledge on anemia in cancer and its treatment with rhEPO is presented and future developments are discussed. Based on a broad spectrum of topics, the book describes the scientific and clinical aspects of anemia in various fields of oncology and gives diagnostic and therapeutic recommendations on when and how to use rhEPO. The book will serve as an authentic and essential source of information for radiotherapists, oncologists, hematologists, internists, pediatricians, surgeons, specialists in transfusion or laboratory medicine and pharmacologists.

Editors and Affiliations

  • Innere Klinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Essen, Universitätsklinikum, Essen, Deutschland

    M. R. Nowrousian

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation